ExCellThera

ExCellThera Inc. is an advanced clinical-stage biotechnology company providing molecular and bioengineering solutions to expand the therapeutic uses of blood stem cells and immune cells. ExCellThera's leading technology, OT-001, combines a patented small molecule, UM171, with an optimized culture system. To offer better treatments to patients, the company is building its product portfolio and supporting first-class clinical trials.